Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA vs Non-PCA IV Hydromorphone for Severe Cancer Pain
NCT03375515Phase 3Completed
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone in cancer pain, sponsored by Fujian Medical University Cancer Hospital. Started Sep 2018; status: completed.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT03375515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375515.